Holen Sie sich die Stockscreener-App
36.47
1.29%
-0.5264
Schlusskurs vom Vortag:
$37.00
Offen:
$36.52
24-Stunden-Volumen:
465.55K
Relative Volume:
0.46
Marktkapitalisierung:
$4.11B
Einnahmen:
$14.09M
Nettoeinkommen (Verlust:
$-176.94M
KGV:
-16.96
EPS:
-2.15
Netto-Cashflow:
$-141.24M
1W Leistung:
+1.06%
1M Leistung:
+19.08%
6M Leistung:
+82.34%
1J Leistung:
+102.56%
1-Tages-Spanne:
$36.34
$37.88
1-Wochen-Bereich:
$35.50
$39.03
52-Wochen-Spanne:
$14.06
$41.47
Newamsterdam Pharma Company Nv Stock (NAMS) Company Profile
Firmenname
Newamsterdam Pharma Company Nv
Sektor
Branche
Telefon
35 206 2971
Adresse
GOOIMEER 2-35, NARRDEN
Vergleichen Sie NAMS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NAMS
Newamsterdam Pharma Company Nv
|
36.48 | 4.17B | 14.09M | -176.94M | -141.24M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.22 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.22 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.73 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
837.59 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.82 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Newamsterdam Pharma Company Nv Stock (NAMS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-20 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-08-25 | Eingeleitet | Wells Fargo | Overweight |
| 2025-07-17 | Eingeleitet | Goldman | Neutral |
| 2025-06-17 | Eingeleitet | Citigroup | Buy |
| 2025-06-10 | Eingeleitet | Stifel | Buy |
| 2025-06-04 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-12-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-05-15 | Eingeleitet | TD Cowen | Buy |
| 2024-03-14 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-01-18 | Eingeleitet | Guggenheim | Buy |
| 2024-01-16 | Eingeleitet | Piper Sandler | Overweight |
| 2023-10-30 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Newamsterdam Pharma Company Nv Aktie (NAMS) Neueste Nachrichten
Will NewAmsterdam Pharma Company N.V. Equity Warrant stock recover faster than marketMarket Trend Review & Community Shared Stock Ideas - newser.com
Using economic indicators to assess NewAmsterdam Pharma Company N.V. Equity Warrant potential2025 Retail Activity & High Return Stock Watch Alerts - newser.com
Is NewAmsterdam Pharma Company N.V. (KH6) stock attractive post correctionQuarterly Profit Summary & Risk Controlled Daily Plans - newser.com
What candlestick patterns are forming on NewAmsterdam Pharma Company N.V. Equity WarrantEntry Point & Safe Capital Investment Plans - newser.com
Can NewAmsterdam Pharma Company N.V. Equity Warrant stock withstand economic slowdownTrade Entry Summary & Entry Point Strategy Guides - newser.com
Can a trend reversal in NewAmsterdam Pharma Company N.V. Equity Warrant lead to recoveryJuly 2025 Sector Moves & Stepwise Trade Execution Plans - newser.com
Is NewAmsterdam Pharma Company N.V. (KH6) stock undervalued by metrics2025 Key Highlights & Precise Buy Zone Tips - newser.com
Is NewAmsterdam Pharma Company N.V. Equity Warrant stock a top pick in earnings season2025 Trading Volume Trends & Community Verified Swing Trade Signals - newser.com
How NewAmsterdam Pharma Company N.V. Equity Warrant stock compares to market leaders2025 Volatility Report & Reliable Trade Execution Plans - newser.com
Is NewAmsterdam Pharma Company N.V. stock a good choice for value investors2025 Pullback Review & Short-Term Trading Opportunity Alerts - newser.com
Why NewAmsterdam Pharma Company N.V. stock is seen as undervaluedRate Cut & Weekly High Potential Stock Alerts - newser.com
Assessing NewAmsterdam Pharma (NasdaqGM:NAMS) Valuation Ahead of Major Phase 3 Data Presentations - simplywall.st
NewAmsterdam Pharma Company N.V. recovery potential after sell offWeekly Profit Report & High Accuracy Swing Entry Alerts - newser.com
Advanced analytics toolkit walkthrough for NewAmsterdam Pharma Company N.V. Equity WarrantQuarterly Growth Report & Daily Momentum Trading Reports - newser.com
How to escape a deep drawdown in NewAmsterdam Pharma Company N.V.Weekly Risk Report & Community Consensus Trade Signals - newser.com
Is NewAmsterdam Pharma Company N.V. stock poised for growthEarnings Summary Report & Growth Oriented Trade Recommendations - newser.com
Why retail investors pile into NewAmsterdam Pharma Company N.V. Equity Warrant stockWeekly Stock Summary & Free Expert Verified Stock Movement Alerts - newser.com
Can NewAmsterdam Pharma Company N.V. (KH6) stock surprise markets with earningsWall Street Watch & Low Drawdown Trading Strategies - newser.com
Visual analytics tools that track NewAmsterdam Pharma Company N.V. Equity Warrant performanceMarket Performance Summary & Fast Entry Momentum Alerts - newser.com
How NewAmsterdam Pharma Company N.V. Equity Warrant stock performs in stagflation2025 Market Outlook & AI Driven Stock Movement Reports - newser.com
Can technical indicators confirm NewAmsterdam Pharma Company N.V. Equity Warrant’s reversalWeekly Trend Summary & Low Risk Entry Point Guides - newser.com
How NewAmsterdam Pharma Company N.V. Equity Warrant stock reacts to oil pricesJuly 2025 Levels & Verified Chart Pattern Trade Signals - newser.com
Will NewAmsterdam Pharma Company N.V. Equity Warrant stock benefit from upcoming earnings reports2025 Trading Volume Trends & Accurate Entry/Exit Alerts - newser.com
How hedge fund analytics apply to NewAmsterdam Pharma Company N.V. stock2025 Valuation Update & High Conviction Buy Zone Alerts - newser.com
Will earnings trigger a reversal in NewAmsterdam Pharma Company N.V. Equity WarrantJuly 2025 Trends & Safe Investment Capital Preservation Plans - newser.com
Pattern recognition hints at NewAmsterdam Pharma Company N.V. upsideMarket Activity Recap & Daily Technical Forecast Reports - newser.com
Will NewAmsterdam Pharma Company N.V. Equity Warrant stock maintain momentum in 2025Share Buyback & Technical Entry and Exit Tips - newser.com
Is NewAmsterdam Pharma Company N.V. Equity Warrant stock trading at a premium valuationJuly 2025 Final Week & Reliable Momentum Entry Alerts - newser.com
Is NewAmsterdam Pharma Company N.V. (KH6) stock prepared for digital transitionMarket Activity Summary & Weekly High Return Stock Forecasts - newser.com
Can volume confirm reversal in NewAmsterdam Pharma Company N.V. Equity WarrantMarket Rally & Community Verified Watchlist Alerts - newser.com
Technical analysis overview for NewAmsterdam Pharma Company N.V. Equity Warrant stockWeekly Market Report & Community Consensus Picks - newser.com
Risk adjusted return profile for NewAmsterdam Pharma Company N.V. Equity Warrant analyzed2025 Growth vs Value & Fast Exit and Entry Strategy Plans - newser.com
Key resistance and support levels for NewAmsterdam Pharma Company N.V.July 2025 Opening Moves & Intraday High Probability Alerts - newser.com
Using data models to predict NewAmsterdam Pharma Company N.V. Equity Warrant stock movement2025 Top Decliners & AI Driven Stock Reports - newser.com
NewAmsterdam Pharma Hits Day High with 8.05% Surge, Strong Intraday Performance - Markets Mojo
Is NewAmsterdam Pharma Company N.V. Equity Warrant stock bottoming outBuy Signal & Fast Moving Stock Watchlists - newser.com
What does recent volatility data suggest for NewAmsterdam Pharma Company N.V. Equity WarrantJuly 2025 Setups & Expert-Curated Trade Recommendations - newser.com
Published on: 2025-11-02 01:19:15 - newser.com
Finanzdaten der Newamsterdam Pharma Company Nv-Aktie (NAMS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.19%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):